---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-164510"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2026-04-21T23:59:59+00:00"
generated_at: "2026-05-15T05:07:20.647392+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prelude Therapeutics prices $90M public offering of common stock and pre-funded warrants

## Summary
- Offering of 18,018,014 common shares at $4.44/share and pre-funded warrants for 2,252,252 shares at $4.4399.
- Gross proceeds ~$90M; net proceeds ~$85.5M after expenses.
- Led by RA Capital Management and Soleus Capital; closes April 21, 2026.
- Proceeds to fund R&D, working capital; extends cash runway into Q2 2028.
- Underwriters: Goldman Sachs, Evercore ISI, Citizens Capital Markets.

## SEC filing metadata
- accession: 0001193125-26-164510
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2026-04-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000119312526164510/0001193125-26-164510-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000119312526164510/d131537d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-164510
- JSON: https://secwatch.observer/filing/0001193125-26-164510.json
- Plain text: https://secwatch.observer/filing/0001193125-26-164510.txt

## Source-grounded claims
- claim_id: e216da7360682b6905f91361d0880b7d48ce6dcd
  claim: Prelude Therapeutics Inc entered into Underwriting Agreement with Goldman Sachs & Co. LLC and Evercore Group L.L.C. (effective 2026-04-20).
  evidence_excerpt: On April 20, 2026, Prelude Therapeutics Incorporated (“Prelude”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC and Evercore Group L.L.C. as representatives (the “Representatives”) of the underwriters named therein
  evidence_url: https://www.sec.gov/Archives/edgar/data/1678660/000119312526164510/0001193125-26-164510-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.